(Q46265378)

20 December 2017

title

An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt (English)

1 reference

20 December 2017

1 reference

meningococcal disease

1 reference

1

G Norheim

1 reference

20 December 2017

5

D A Caugant

1 reference

20 December 2017

author name string

G Tunheim

2

1 reference

20 December 2017

L M Næss

3

1 reference

20 December 2017

P A Kristiansen

4

1 reference

20 December 2017

E Rosenqvist

6

1 reference

20 December 2017

publication date

1 August 2012

1 reference

20 December 2017

Scandinavian Journal of Immunology

published in

1 reference

20 December 2017

volume

76

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

99-107

1 reference

20 December 2017

Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Naturally-acquired immunity to Neisseria meningitidis group A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

A universal vaccine for serogroup B meningococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

PorA variable regions of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

NadA diversity and carriage in Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Recent advances in the large scale fermentation of Neisseria meningitidis group B for the production of an outer membrane protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Measurements of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Epidemic spread and antigenic variability of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02709.X

10.1111/J.1365-3083.2012.02709.X

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017